Your browser doesn't support javascript.
loading
Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events.
Wu, Feitong; Juonala, Markus; Jacobs, David R; Daniels, Stephen R; Kähönen, Mika; Woo, Jessica G; Sinaiko, Alan R; Viikari, Jorma S A; Bazzano, Lydia A; Burns, Trudy L; Steinberger, Julia; Urbina, Elaine M; Venn, Alison J; Raitakari, Olli T; Dwyer, Terence; Magnussen, Costan G.
Afiliação
  • Wu F; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (F.W., A.J.V., T.D., C.G.M.).
  • Juonala M; Baker Heart and Diabetes Institute, Melbourne, Australia (F.W., C.G.M.).
  • Jacobs DR; Baker Department of Cardiometabolic Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia (F.W.).
  • Daniels SR; Department of Medicine, University of Turku, Finland (M.J., J.S.J.V.).
  • Kähönen M; Division of Medicine, Turku University Hospital, Finland (M.J., J.S.J.V.).
  • Woo JG; Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis (D.R.J.).
  • Sinaiko AR; Department of Pediatrics, University of Colorado School of Medicine, Children's Hospital Colorado, Aurora (S.R.D.).
  • Viikari JSA; Faculty of Medicine and Health Technology, Tampere University, Finland (M.K.).
  • Bazzano LA; Department of Clinical Physiology, Tampere University Hospital, Finland (M.K.).
  • Burns TL; Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, and Department of Pediatrics, University of Cincinnati College of Medicine, OH (J.G.W.).
  • Steinberger J; University of Minnesota Medical School, Minneapolis (A.R.S.).
  • Urbina EM; Department of Medicine, University of Turku, Finland (M.J., J.S.J.V.).
  • Venn AJ; Division of Medicine, Turku University Hospital, Finland (M.J., J.S.J.V.).
  • Raitakari OT; Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA (L.A.B.).
  • Dwyer T; Department of Epidemiology, College of Public Health, University of Iowa, Iowa City (T.L.B.).
  • Magnussen CG; Department of Pediatrics, University of Minnesota School of Medicine, Minneapolis (J.S.).
Circulation ; 149(3): 217-226, 2024 01 16.
Article em En | MEDLINE | ID: mdl-38014550
ABSTRACT

BACKGROUND:

Although low-density lipoprotein cholesterol (LDL-C) remains the primary cholesterol target in clinical practice in children and adults, non-high-density lipoprotein cholesterol (non-HDL-C) has been suggested as a more accurate measure of atherosclerotic cardiovascular disease (ASCVD) risk. We examined the associations of childhood non-HDL-C and LDL-C levels with adult ASCVD events and determined whether non-HDL-C has better utility than LDL-C in predicting adult ASCVD events.

METHODS:

This prospective cohort study included 21 126 participants from the i3C Consortium (International Childhood Cardiovascular Cohorts). Proportional hazards regressions were used to estimate the risk for incident fatal and fatal/nonfatal ASCVD events associated with childhood non-HDL-C and LDL-C levels (age- and sex-specific z scores; concordant/discordant categories defined by guideline-recommended cutoffs), adjusted for sex, Black race, cohort, age at and calendar year of child measurement, body mass index, and systolic blood pressure. Predictive utility was determined by the C index.

RESULTS:

After an average follow-up of 35 years, 153 fatal ASCVD events occurred in 21 126 participants (mean age at childhood visits, 11.9 years), and 352 fatal/nonfatal ASCVD events occurred in a subset of 11 296 participants who could be evaluated for this outcome. Childhood non-HDL-C and LDL-C levels were each associated with higher risk of fatal and fatal/nonfatal ASCVD events (hazard ratio ranged from 1.27 [95% CI, 1.14-1.41] to 1.35 [95% CI, 1.13-1.60] per unit increase in the risk factor z score). Non-HDL-C had better discriminative utility than LDL-C (difference in C index, 0.0054 [95% CI, 0.0006-0.0102] and 0.0038 [95% CI, 0.0008-0.0068] for fatal and fatal/nonfatal events, respectively). The discordant group with elevated non-HDL-C and normal LDL-C had a higher risk of ASCVD events compared with the concordant group with normal non-HDL-C and LDL-C (fatal events hazard ratio, 1.90 [95% CI, 0.98-3.70]; fatal/nonfatal events hazard ratio, 1.94 [95% CI, 1.23-3.06]).

CONCLUSIONS:

Childhood non-HDL-C and LDL-C levels are associated with ASCVD events in midlife. Non-HDL-C is better than LDL-C in predicting adult ASCVD events, particularly among individuals who had normal LDL-C but elevated non-HDL-C. These findings suggest that both non-HDL-C and LDL-C are useful in identifying children at higher risk of ASCVD events, but non-HDL-C may provide added prognostic information when it is discordantly higher than the corresponding LDL-C and has the practical advantage of being determined without a fasting sample.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Aterosclerose Limite: Adult / Child / Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Aterosclerose Limite: Adult / Child / Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article